These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3365743)

  • 21. [Tavanik effectiveness and safety in the treatment of urinary tract infection complications].
    Loran OB; Pushkar' DIu; Rasner PI
    Klin Med (Mosk); 2001; 79(12):35-8. PubMed ID: 11840809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ciprofloxacin versus cinoxacin in therapy of urinary tract infections. A randomized, double-blind trial.
    Goldstein EJ; Kahn RM; Alpert ML; Ginsberg BP; Greenway FL; Citron DM
    Am J Med; 1987 Apr; 82(4A):284-7. PubMed ID: 3555049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New approaches to the treatment of urinary tract infection.
    Tolkoff-Rubin NE; Rubin RH
    Am J Med; 1987 Apr; 82(4A):270-7. PubMed ID: 3555047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral ciprofloxacin in the treatment of elderly patients with complicated urinary tract infections due to trimethoprim/sulfamethoxazole-resistant bacteria.
    Preheim LC; Cuevas TA; Roccaforte JS; Mellencamp MA; Bittner MJ
    Am J Med; 1987 Apr; 82(4A):295-300. PubMed ID: 3555051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Criteria for use of intravenous ciprofloxacin for infections in adult patients.
    Frisolone J; Manzo J; Leviton IM
    Clin Pharm; 1993 Mar; 12(3):226-32. PubMed ID: 8491080
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of oral ciprofloxacin on fecal bacteria in elderly patients.
    Höffler U; Grünig F; Brehmer B
    J Chemother; 1989 Jul; 1(4 Suppl):617-8. PubMed ID: 16312558
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of short-term treatment regimen of ciprofloxacin versus long-term treatment regimens of trimethoprim/sulfamethoxazole or norfloxacin for uncomplicated lower urinary tract infections: a randomized, multicentre, open-label, prospective study.
    Arredondo-García JL; Figueroa-Damián R; Rosas A; Jáuregui A; Corral M; Costa A; Merlos RM; Ríos-Fabra A; Amábile-Cuevas CF; Hernández-Oliva GM; Olguín J; Cardeñosa-Guerra O;
    J Antimicrob Chemother; 2004 Oct; 54(4):840-3. PubMed ID: 15347634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prospective, randomized trial of 3 or 14 days of ciprofloxacin treatment for acute urinary tract infection in patients with spinal cord injury.
    Dow G; Rao P; Harding G; Brunka J; Kennedy J; Alfa M; Nicolle LE
    Clin Infect Dis; 2004 Sep; 39(5):658-64. PubMed ID: 15356779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of three dosage regimens of ciprofloxacin in urinary tract infections.
    Prát V; Horcicková M; Matousovic K; Hatala M
    Int Urol Nephrol; 1990; 22(3):201-7. PubMed ID: 2210972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral ciprofloxacin in resistant urinary tract infections.
    Ryan JL; Berenson CS; Greco TP; Mangi RJ; Sims M; Thornton GF; Andriole VT
    Am J Med; 1987 Apr; 82(4A):303-6. PubMed ID: 3555052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bay o 9867 (ciprofloxacin) in the treatment of urinary tract infections in elderly patients.
    Vellucci A; De Rosa F; Bernardini G; Di Vico B
    Riv Eur Sci Med Farmacol; 1988 Aug; 10(4):333-9. PubMed ID: 3274909
    [No Abstract]   [Full Text] [Related]  

  • 32. Single-dose ciprofloxacin at 100 versus 250 mg for treatment of uncomplicated urinary tract infections in women.
    Garlando F; Rietiker S; Täuber MG; Flepp M; Meier B; Lüthy R
    Antimicrob Agents Chemother; 1987 Feb; 31(2):354-6. PubMed ID: 3551837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid resolution of symptoms with ciprofloxacin therapy in 3859 hospitalised patients with urinary tract infection.
    Naber KG; Landen H
    Int J Antimicrob Agents; 2004 Mar; 23 Suppl 1():S35-40. PubMed ID: 15037327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single-dose ciprofloxacin in the treatment of uncomplicated urinary tract infection in women.
    Raz R; Rottensterich E; Hefter H; Kennes Y; Potasman I
    Eur J Clin Microbiol Infect Dis; 1989 Dec; 8(12):1040-2. PubMed ID: 2620672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ciprofloxacin: an update on clinical experience.
    Arcieri G; Griffith E; Gruenwaldt G; Heyd A; O'Brien B; Becker N; August R
    Am J Med; 1987 Apr; 82(4A):381-6. PubMed ID: 3555063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of ciprofloxacin and beta-lactam antibiotics in the treatment of urinary tract infections and alteration of fecal flora.
    Daikos GL; Kathpalia SB; Sharifi R; Lolans VT; Jackson GG
    Am J Med; 1987 Apr; 82(4A):290-4. PubMed ID: 3555050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antibacterial activity of ciprofloxacin in the urine during four days after a single 500 mg and 750 mg oral dose].
    Guibert J; Kitzis MD; Acar JF
    Pathol Biol (Paris); 1994 Jun; 42(6):587-92. PubMed ID: 7854859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of ciprofloxacin as a prophylactic agent in urinary tract infections in renal transplant recipients.
    Moysés Neto M; Costa RS; Reis MA; Ferraz AS; Saber LT; Batista ME; Muglia V; Garcia TM; Figueiredo JF
    Clin Transplant; 1997 Oct; 11(5 Pt 1):446-52. PubMed ID: 9361939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The efficacy and tolerance of Bay-o-9867 (ciprofloxacin) in the treatment of infections of the urinary tract and of the lower respiratory tract].
    Quartieri F; Bolognesi S; Sconosciuto F
    Recenti Prog Med; 1994 Feb; 85(2):96-100. PubMed ID: 8184195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antibiotic prophylaxis in transrectal prostate biopsy. Short-term vs. long-term therapy].
    Peters HJ; Breitling P
    Urologe A; 2003 Jan; 42(1):91-4. PubMed ID: 14655644
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.